FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2902023274> ?p ?o ?g. }

• W2902023274 endingPage "6693" @default.
• W2902023274 startingPage "6685" @default.
• W2902023274 abstract "IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis Landon Browning,1,* Megha R Patel,2,* Eli Bring Horvath,3 Ken Tawara,3,4 Cheryl L Jorcyk3,4 1University of Washington School of Medicine, Seattle, WA 98195, USA; 2University of California Riverside School of Medicine, Riverside, CA 92521, USA; 3Department of Biological Sciences, Boise State University, Boise, ID 83725, USA; 4Biomolecular Sciences Program, Boise State University, Boise, ID 83725, USA *These authors contributed equally to this work Abstract: Ovarian cancer is the most fatal gynecological cancer in the USA and the fifth most common cancer-related cause of death in women. Inflammation has been shown to play many roles in ovarian cancer tumor growth, with the proinflammatory cytokine interleukin-6 (IL-6) having been established as a key immunoregulatory cytokine. Ovarian cancer cells continuously secrete cytokines that promote tumorigenicity in both autocrine and paracrine fashions while also receiving signals from the tumor microenvironment (TME). The TME contains many cells including leukocytes and fibroblasts, which respond to proinflammatory cytokines and secrete their own cytokines, which can produce many effects including promotion of chemoresistance, resistance to apoptosis, invasion, angiogenesis by way of overexpression of vascular endothelial growth factor, and promotion of metastatic growth at distant sites. IL-6 and its proinflammatory family members, including oncostatin M, have been found to directly stimulate enhanced invasion of cancer cells through basement membrane degradation caused by the overexpression of matrix metalloproteinases, stimulate promotion of cell cycle, enhance resistance to chemotherapy, and cause epithelial-to-mesenchymal transition (EMT). IL-6 has been shown to activate signaling pathways that lead to tumor proliferation, the most studied of which being the Janus kinase (JAK) and STAT3 pathway. IL-6-induced JAK/STAT activation leads to constitutive activation of STAT3, which has been correlated with enhanced tumor cell growth and resistance to chemotherapy. IL-6 has also been shown to act as a trigger of the EMT, the hypothesized first step in the metastatic cascade. Understanding the important role of IL-6 and its family members’ effects on the pathogenesis of ovarian cancer tumor growth and metastasis may lead to more novel treatments, detection methods, and improvement of overall clinical outcomes. Keywords: interleukin-6, IL-6, OSM, inflammatory cytokines, ovarian cancer, metastasis" @default.
• W2902023274 created "2018-12-11" @default.
• W2902023274 creator A5039634836 @default.
• W2902023274 creator A5041589856 @default.
• W2902023274 creator A5049941245 @default.
• W2902023274 creator A5063171473 @default.
• W2902023274 creator A5075529661 @default.
• W2902023274 date "2018-12-01" @default.
• W2902023274 modified "2023-10-14" @default.
• W2902023274 title "IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis" @default.
• W2902023274 cites W1554802713 @default.
• W2902023274 cites W1953357409 @default.
• W2902023274 cites W1968814677 @default.
• W2902023274 cites W1970173043 @default.
• W2902023274 cites W1976560584 @default.
• W2902023274 cites W1977861166 @default.
• W2902023274 cites W1987318948 @default.
• W2902023274 cites W1987525605 @default.
• W2902023274 cites W1988005161 @default.
• W2902023274 cites W1991242976 @default.
• W2902023274 cites W2005598650 @default.
• W2902023274 cites W2006992975 @default.
• W2902023274 cites W2007998678 @default.
• W2902023274 cites W2014881943 @default.
• W2902023274 cites W2016360721 @default.
• W2902023274 cites W2027913125 @default.
• W2902023274 cites W2028391341 @default.
• W2902023274 cites W2029520352 @default.
• W2902023274 cites W2042633087 @default.
• W2902023274 cites W2045648996 @default.
• W2902023274 cites W2046576445 @default.
• W2902023274 cites W2053271495 @default.
• W2902023274 cites W2059815344 @default.
• W2902023274 cites W2061977596 @default.
• W2902023274 cites W2063491848 @default.
• W2902023274 cites W2065400371 @default.
• W2902023274 cites W2073114027 @default.
• W2902023274 cites W2074601175 @default.
• W2902023274 cites W2078828659 @default.
• W2902023274 cites W2082626794 @default.
• W2902023274 cites W2083798214 @default.
• W2902023274 cites W2085776836 @default.
• W2902023274 cites W2085793397 @default.
• W2902023274 cites W2086840459 @default.
• W2902023274 cites W2087486104 @default.
• W2902023274 cites W2088356680 @default.
• W2902023274 cites W2088434784 @default.
• W2902023274 cites W2095818256 @default.
• W2902023274 cites W2096166085 @default.
• W2902023274 cites W2100476458 @default.
• W2902023274 cites W2102677576 @default.
• W2902023274 cites W2110994269 @default.
• W2902023274 cites W2113324742 @default.
• W2902023274 cites W2116554142 @default.
• W2902023274 cites W2119145947 @default.
• W2902023274 cites W2125124220 @default.
• W2902023274 cites W2125933228 @default.
• W2902023274 cites W2126150441 @default.
• W2902023274 cites W2127387778 @default.
• W2902023274 cites W2130777678 @default.
• W2902023274 cites W2131930163 @default.
• W2902023274 cites W2132757902 @default.
• W2902023274 cites W2135422412 @default.
• W2902023274 cites W2137541604 @default.
• W2902023274 cites W2138941973 @default.
• W2902023274 cites W2144737008 @default.
• W2902023274 cites W2147807172 @default.
• W2902023274 cites W2152295044 @default.
• W2902023274 cites W2153602227 @default.
• W2902023274 cites W2157426885 @default.
• W2902023274 cites W2161556041 @default.
• W2902023274 cites W2166757954 @default.
• W2902023274 cites W2170987896 @default.
• W2902023274 cites W2220753614 @default.
• W2902023274 cites W2235523093 @default.
• W2902023274 cites W2298075693 @default.
• W2902023274 cites W2305551225 @default.
• W2902023274 cites W2346650944 @default.
• W2902023274 cites W2351856897 @default.
• W2902023274 cites W2404435895 @default.
• W2902023274 cites W2411537421 @default.
• W2902023274 cites W2435180223 @default.
• W2902023274 cites W2610204288 @default.
• W2902023274 cites W2770430263 @default.
• W2902023274 cites W2781525129 @default.
• W2902023274 cites W2886482717 @default.
• W2902023274 cites W88943984 @default.
• W2902023274 doi "https://doi.org/10.2147/cmar.s179189" @default.
• W2902023274 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6287645" @default.
• W2902023274 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30584363" @default.
• W2902023274 hasPublicationYear "2018" @default.
• W2902023274 type Work @default.
• W2902023274 sameAs 2902023274 @default.
• W2902023274 citedByCount "159" @default.
• W2902023274 countsByYear W29020232742019 @default.
• W2902023274 countsByYear W29020232742020 @default.
• W2902023274 countsByYear W29020232742021 @default.
• W2902023274 countsByYear W29020232742022 @default.

• next